Exam
Cirrhotic Ascites
search
Cirrhotic Ascites
, Hepatic Ascites
See Also
Ascites
Ascites Causes
Cirrhosis
Epidemiology
Most common complication of
Cirrhosis
Presents in 60% of patients within 10 years of
Cirrhosis
diagnosis
Pathophysiology
Portal Hypertension
Results in increased splanchnic
Blood Volume
with increased nitric oxide production
Secondary splanchnic and arterial vasodilation
Kidney
s sense decreased perfusion
Activates
Renin-Angiotensin System
Results in increased
Sodium
and water retention
Hypoalbuminemia and decreased oncotic pressure
Increased splanchnic pressure overcomes oncotic pressure
Transudate leaks into peritoneum
Evaluation
See
Paracentesis
Diagnostic
Paracentesis
Indications
Exclude
Spontaneous Bacterial Peritonitis
(keep a low threshold for evaluation)
Exclude extrahepatic causes of
Ascites
(see
Ascites
)
Unexplained
Ascites
New onset
Ascites
Hospitalized patients
Clinical deterioration
Ascites
characteristics
Portal Hypertension
(
Cirrhosis
)
Serum Albumin
-
Ascites
Albumin exceeds 1.1 mg/dl
Ascites
not due to
Portal Hypertension
Albumin gradient (see above) <1.1 mg/dl
Consider other
Ascites Causes
Peritoneal carcinomatosis
Abdominal
Tuberculosis
Spontaneous Bacterial Peritonitis
Ascitic Fluid Culture (at least 20 ml fluid)
Split between 2 culture bottles (10 ml each), one aerobic and one anaerobic
False Negative
in 60% of cases
Ascitic Fluid cell count and differential
Total
White Blood Cell
s (WBC ,
Leukocyte
s) > 500/mm3
Neutrophil
s (PMNs) > 250/mm3
Test Sensitivity
and
Test Specificity
: 93-94%
Differential Diagnosis
See
Ascites Causes
Management
Medical Management
See
Spontaneous Bacterial Peritonitis
Sodium
restriction
Maximum salt intake: 2 grams per day
Salt Restriction
controls
Ascites
in 10-20% patients
Diuretic
s
Spironolactone
(
Aldactone
)
Start 25-50 mg three times daily to four times daily (max 100 mg/day in divided dosing)
Increase as needed by 100 mg every 3 days (max 400 mg/day in divided dosing)
Effective in 40-75% of cases
Furosemide
(
Lasix
)
Start 40 mg orally daily
Increase as needed up to 160 mg/day in divided dosing (e.g. twice daily)
Goal
Urine Sodium
exceeds
Urine Potassium
Do not allow
Serum Creatinine
to rise over 3.0
Contraindications (reasons to avoid, decrease or eliminate
Diuretic
s
Hyponatremia
<125 meq/L
Hypokalemia
Hyperkalemia
Acute Kidney Injury
Severe
Muscle
cramps
Fluid Restriction
Indicated for
Serum Sodium
<125 meq/L
Limit to 1 to 1.5 L/day maximum if indicated
Avoid provocative agents
Avoid
NSAID
s (increase renal
Sodium
retention)
Avoid
Beta Blocker
s,
ACE Inhibitor
s and
Angiotensin Receptor Blocker
s
Associated with increased
Hypovolemia
and
Hypotension
risk
Prophylactic
Antibiotic
s (for prevention of
Spontaneous Bacterial Peritonitis
)
Indications
Liver
failure (
Child-Pugh Score
>=9 and
Serum Bilirubin
>= 3 mg/dl)
Renal dysfunction (
Serum Creatinine
>=1.2 mg/dl) or
Hyponatremia
(
Serum Sodium
<130 mEq/L)
Ascitic fluid
Protein
<15 g/L
Protocol
Ciprofloxacin
400 mg orally daily
Management
Interventions
Therapeutic
Paracentesis
Indications
Required in up to 10% of cases
Up to 4-6 liters may be safely removed per
Paracentesis
without albumin replacement
Risk of
Paracentesis
-induced circulatory dysfunction (PICD) with large volume
Paracentesis
Replace albumin if >6 Liters are removed
Give 6 to 8 g/L of
Ascites
removed
Indications
Significant patient discomfort (tense
Ascites
)
Respiratory compromise
Large
Umbilical Hernia
Recurrent
Bacteria
l peritonitis
Refractory
Ascites
Mortality approaches 20% in 6 months
Consider
Palliative Care
referral if not a
Liver Transplant
candidate
Temporizing measures
Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Peritoneovenous Shunt
Liver Transplant
ation
See
Cirrhosis
Consider for all cirrhotic patients with
Ascites
Prognosis
Associated with increased mortality risk
Poor prognostic sign for
Cirrhosis
course
Complications
Spontaneous Bacterial Peritonitis
Umbilical Hernia
with risk of rupture
References
Swencki (2015) Crit Dec Emerg Med 29(11):2-10
Garcia (2001) Postgrad Med 109(2):91-103 [PubMed]
Keating (2022) Am Fam Physician 105(4): 412-20 [PubMed]
Zervos (2001) Am J Surg 181(3):256-64 [PubMed]
Type your search phrase here